A novel treatment strategy targeting shugoshin 1 in hematological malignancies

Leukemia Research

Volumn 37, Issue 1, 2013, Pages 76-82

  Yang, Jing ^a   Ikezoe, Takayuki ^a   Nishioka, Chie ^a   Yokoyama, Akihito ^a  

^a KOCHI UNIVERSITY   (Japan)

Author keywords

AML; Apoptosis; BubR1; Shugoshin (SGOL); Spindle checkpoint

Indexed keywords

BUB1 RELATED PROTEIN; CASPASE; MESSENGER RNA; NUCLEAR PROTEIN; SHUGOSHIN 1; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ACUTE GRANULOCYTIC LEUKEMIA; APOPTOSIS; ARTICLE; CELL CYCLE ARREST; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CELL PROLIFERATION; CENTROMERE; COLONY FORMING UNIT GM; COLONY FORMING UNIT M; CONTROLLED STUDY; GENE EXPRESSION; GENE REPRESSION; HEMATOLOGIC MALIGNANCY; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; LEUKEMIA CELL; MONONUCLEAR CELL; ONCOGENE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; SISTER CHROMATID; UPREGULATION;

APOPTOSIS; CELL CYCLE CHECKPOINTS; CELL CYCLE PROTEINS; CELL DIVISION; CELL LINE, TUMOR; G2 PHASE; HUMANS; LEUKEMIA; RNA, MESSENGER; RNA, SMALL INTERFERING;

EID: 84870887793     PISSN: 01452126     EISSN: 18735835     Source Type: Journal    
DOI: 10.1016/j.leukres.2012.10.002     Document Type: Article

References (24)

1. Lowenberg B., Downing J.R., Burnet A. Acute myeloid leukemia. N Engl J Med 1999, 341:1051-1062.
2. Wolff S.N., Herzig R.H., Fay J.W., Phillips G.L., Lazarus H.M., Flexner J.M., et al. High-dose cytarabine and daunorubicin as consolidation therapy for acute myeloid leukemia in first remission: long-term follow-up and results. J Clin Oncol 1989, 7:1260-1267.
3. Kitajima T.S., Kawashima S.A., Watanabe Y. The conserved kinetochore protein shugoshin protects centromeric cohesion during meiosis. Nature 2004, 427:510-517.
4. Watanabe Y. Modifying sister chromatid cohesion for meiosis. J Cell Sci 2004, 117:4017-4023.
5. Salic A., Waters J.C., Mitchison T.J. Vertebrate shugoshin links sister centromere cohesion and kinetochore microtubule stability in mitosis. Cell 2004, 118:567-578.
6. McGuinness B.E., Hirota T., Kudo N.R., Peters J.M., Nasmyth K. Shugoshin prevents dissociation of cohesin from centromeres during mitosis in vertebrate cells. PLoS Biol 2005, 3:e86.
7. Tanno Y., Kitajima T.S., Honda T., Ando Y., Ishiguro K., Watanabe Y. Phosphorylation of mammalian Sgo2 by Aurora B recruits PP2A and MCAK to centromeres. Genes Dev 2010, 24:2169-2179.
8. Liu L., Zhang N., Liu J., Min J., Ma N., Liu N., et al. Lentivirus-mediated siRNA interference targeting SGO-1 inhibits human NSCLC cell growth. Tumour Biol 2012, 33:515-521.
9. Musacchio A., Salmon E.D. The spindle-assembly checkpoint in space and time. Nat Rev Mol Cell Biol 2007, 8:379-393.
10. Rieder C.L., Schultz A., Cole R., Sluder G. Anaphase onset in vertebrate somatic cells is controlled by a checkpoint that monitors sister kinetochore attachment to the spindle. J Cell Biol 1994, 127:1301-1310.
11. Gabrielli B., Chau Y.Q., Giles N., Harding A., Stevens F., Beamish H. Caffeine promotes apoptosis in mitotic spindle checkpoint-arrested cells. J Biol Chem 2007, 282:6954-6964.
12. Du Y., Yin F., Liu C., Wang J., Xie H., Hong L., et al. Depression of MAD2 inhibits apoptosis of gastric cancer cells by upregulating Bcl-2 and interfering mitochondrion pathway. Biochem Biophys Res Commun 2006, 345:1092-1098.
13. Spierings D., McStay G., Saleh M., Bender C., Chipuk J., Maurer U., et al. Connected to death: the (unexpurgated) mitochondrial pathway of apoptosis. Science 2005, 310:66-67.
14. Ikezoe T., Nishioka C., Tasaka T., Yang Y., Komatsu N., Togitani K., et al. The antitumor effects of sunitinib (formerly SU11248) against a variety of human hematologic malignancies: enhancement of growth inhibition via inhibition of mammalian target of rapamycin signaling. Mol Cancer Ther 2006, 5:2522-2530.
15. Ikezoe T., Tanosaki S., Krug U., Liu B., Cohen P., Taguchi H., et al. Insulin-like growth factor binding protein-3 antagonizes the effects of retinoids in myeloid leukemia cells. Blood 2004, 104:237-242.
16. Yang J., Ikezoe T., Nishioka C., Tasaka T., Taniguchi A., Kuwayama Y., et al. AZD1152, a novel and selective aurora B kinase inhibitor, induces growth arrest, apoptosis, and sensitization for tubulin depolymerizing agent or topoisomerase II inhibitor in human acute leukemia cells in vitro and in vivo. Blood 2007, 110:2034-2040.
17. Seabright M. A rapid banding technique for human chromosomes. Lancet 1973, 197:971-972.
18. Greene L.M., Campiani G., Lawler M., Williams D.C., Zisterer D.M. BubR1 is required for a sustained mitotic spindle checkpoint arrest in human cancer cells treated with tubulin-targeting pyrrolo-1,5-benzoxazepines. Mol Pharmacol 2008, 73:419-430.
19. Tang Z., Sun Y., Harley S.E., Zou H., Yu H. Human Bub1 protects centromeric sister-chromatid cohesion through Shugoshin during mitosis. Proc Natl Acad Sci USA 2004, 101:18012-18017.
20. Adams J.M., Cory S. The Bcl-2 protein family: arbiters of cell survival. Science 1998, 281:1322-1326.
21. Kang M.H., Reynolds C.P. Bcl-2 inhibitors: targeting mitochondrial apoptotic pathways in cancer therapy. Clin Cancer Res 2009, 15:1126-1132.
22. Ikezoe T., Yang J., Nishioka C., Tasaka T., Taniguchi A., Kuwayama Y., et al. A novel treatment strategy targeting Aurora kinases in acute myelogenous leukemia. Mol Cancer Ther 2007, 6:1851-1857.
23. Hendrikse A.S., Hunter A.J., Keraan M., Blekkenhorst G.H. Effects of low dose irradiation on TK6 and U937 cells: induction of p53 and its role in cell-cycle delay and the adaptive response. Int J Radiat Biol 2000, 76:11-21.
24. Ikezoe T., Yang J., Nishioka C., Yokoyama A. p53 is critical for the Aurora B kinase inhibitor-mediated apoptosis in acute myelogenous leukemia cells. Int J Hematol 2010, 91:69-77.